Moving in the Right Direction: Cocrystals and the FDA

Read More

Using Solid Form Patents to Protect Pharmaceutical Products — Part I

Read More

Using Solid Form Patents to Protect Pharmaceutical Products — Part II

Read More

NEWS & EVENTS

EVENTS
IPWatchdog Webinar:
Drug Repositioning and Lifecycle Management: A Solid-Form Patent Strategy
December 1st, 2020
12:00-1:00PM EST
Eyal Barash of Barash Law LLC and Steef Boerrigter of AMRI SSCI, LLC will be speaking in a panel discussion webinar on December 1st at 12:00PM ET. The seminar will introduce the science behind solid forms and how they are protected as valuable intellectual property.
Register
EVENTS
AAPS eChalk Talk:
Surveying the Exclusivity and Patent Status of Remdesivir
January 28th, 2020
11:00AM EST
Remdesivir is the first approved therapy for COVID-19, having first received an Emergency Use Authorization and then finally full approval on October 22, 2020.  Asa fully approved drug, the FDA has provided the public with both regulatory exclusivity and patent information.  In this presentation, we will review that information, discuss what it means, and relate that to typical strategies used by innovator companies to protect valuable assets.
Registration Info Coming Soon

QUESTIONS ANSWERED

What is a solid form?

A solid form is the solid representation of a chemical compound.  Examples include polymorphs, salts, solvates, hydrates, cocrystals, and amorphous solids.

Why patent solid forms?

Solid forms are compositions of matter and Orange-Book listable as drug substance.  When the science is right, patenting follows.

How do you patent a solid form?

The same rules apply to solid forms as to any other inventions.  Careful attention should be paid to the kinds and quality of data used in solid form patents.

WHAT WE DO

pharmaceutical patents

Orange-Book Listable Patents Add Value

deals


Intellectual Property as Deal Currency

ip strategy and execution

A Strategy Requires a Realistic Plan

in-house
counsel

Legal Functionality as a Business Driver